Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Cancer Treatment and Research Communications
|
September 18, 2025
Trends in breast cancer in Indonesia from 2017 to 2020: A national-level analysis by age and disease severity
Sudewi Mukaromah Khoirunnisa, Didik Setiawan, Maarten J Postma, et al.
Clinical Therapeutics
|
February 1, 2017
Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands
Lisa A de Jong, Evgeni Dvortsin, Kristel J Janssen, et al.
Pharmacoeconomics - Open
|
September 20, 2019
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
Judith J Gout-Zwart, Lisa A de Jong, Lisanne Saptenno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 25, 2023
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies - can alignment be improved?
Sharon Wolters, Lisa A de Jong, Christel Jansen, et al.
BMJ Open
|
January 14, 2021
Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
Lisa A de Jong, Annette W G van der Velden, Marinus van Hulst, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 29, 2017
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Maartje S Jacobs, Lisa A de Jong, Maarten J Postma, et al.
Journal of Medical Internet Research
|
September 26, 2023
The Use of eHealth for Pharmacotherapy Management With Patients With Respiratory Disease, Cardiovascular Disease, or Diabetes: Scoping Review
Robbert Bakema, Daria Smirnova, Despina Biri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Author's Reply
Simon van der Pol, Lisa A de Jong, Pepijn Vemer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 30, 2019
Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier
Simon van der Pol, Lisa A de Jong, Pepijn Vemer, et al.
Plos One
|
February 27, 2025
Early economic evaluation of chelation therapy in kidney transplant recipients with high-normal lead
Jiasi Hao, Behrooz Z Alizadeh, Maarten J Postma, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Cancer Treatment and Research Communications
|
September 18, 2025
Trends in breast cancer in Indonesia from 2017 to 2020: A national-level analysis by age and disease severity
Sudewi Mukaromah Khoirunnisa, Didik Setiawan, Maarten J Postma, et al.
Clinical Therapeutics
|
February 1, 2017
Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands
Lisa A de Jong, Evgeni Dvortsin, Kristel J Janssen, et al.
Pharmacoeconomics - Open
|
September 20, 2019
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
Judith J Gout-Zwart, Lisa A de Jong, Lisanne Saptenno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 25, 2023
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies - can alignment be improved?
Sharon Wolters, Lisa A de Jong, Christel Jansen, et al.
BMJ Open
|
January 14, 2021
Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
Lisa A de Jong, Annette W G van der Velden, Marinus van Hulst, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 29, 2017
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Maartje S Jacobs, Lisa A de Jong, Maarten J Postma, et al.
Journal of Medical Internet Research
|
September 26, 2023
The Use of eHealth for Pharmacotherapy Management With Patients With Respiratory Disease, Cardiovascular Disease, or Diabetes: Scoping Review
Robbert Bakema, Daria Smirnova, Despina Biri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Author's Reply
Simon van der Pol, Lisa A de Jong, Pepijn Vemer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 30, 2019
Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier
Simon van der Pol, Lisa A de Jong, Pepijn Vemer, et al.
Plos One
|
February 27, 2025
Early economic evaluation of chelation therapy in kidney transplant recipients with high-normal lead
Jiasi Hao, Behrooz Z Alizadeh, Maarten J Postma, et al.
Page
of 2